We have treated almost 100,000 patients on our mission to save one million lives.

Recovery Centers of America

What Is 7-OH and Why Are Kratom Products Raising Health Concerns?

Federal regulators are taking action against certain kratom-derived compounds as concerns grow about the potential for dependence and addiction. 7-hydroxymitragynine (7-OH) is a concentrated, psychoactive compound derived from kratom that can produce opioid-like effects. While kratom products are often marketed as natural or wellness products, concentrated extracts and derivatives such as 7-OH may carry significant risks, particularly with frequent or prolonged use.

Dr. Myles Jen Kin, Medical Director with Recovery Centers of America, told CNN that he has seen a significant increase in people experiencing kratom-related dependence. He noted that cases at RCA facilities have grown from approximately one per week a year ago to roughly 10 per week today. “I think this is a necessary regulation that needs to happen,” he said. For people struggling to stop using kratom or 7-OH, medically supervised addiction treatment can provide a safe, supportive path toward recovery.

Click here to read full article

Source: CNN, August 31, 2026, by Kristen Rogers

RCA’s personalized, evidence-based care combined with the compassion and understanding of our staff has helped nearly 100,000 patients achieve lasting recovery. If you or a loved one is struggling with addiction or mental health, we are here to help. Call 1.800.RECOVERY or contact us online today.

Recent News

Stay Up to Date With RCA Media Alerts

Subscribe to receive RCA press releases, media announcements, expert insights, and updates on our work in addiction treatment, recovery, and mental health.

Share Article

Stay Up to Date With RCA Media Alerts

Subscribe to receive RCA press releases, media announcements, expert insights, and updates on our work in addiction treatment, recovery, and mental health.

Share Article

More Like This

Substances Treated
Insurance Accepted
Frequently Asked Questions

News and Press Releases Subscription Form

 
×